|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Causes of death among human immunodeficiency virus (HIV)-infected a- dults in the era of potent antiretroviral therapy: emer ging role of hepatitis and cancers, persistent role of AIDS显示文摘 | Lewden C Salmon D Morlat P | 2005 | Int J Epidemiol2005，34，1： | 1 |
| 2 | Photodegradation of polypropylene nanocomposites显示文摘 | MAILHOT B MORLAT S GARDETTE J | 2003 | Polym Degrad Stab2003，82，2： | 1 |
| 3 | First results on the effects of controlled permanent cover on the vine and wine,in combination with soil diversity of Saumur vineyards显示文摘 | Riou C Morlat R | 1996 | Seizieme Conference du Columa Tome1996，3，： | 1 |
| 4 | Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic)显示文摘 | Charlotte Lewden Thierry May Eric Rosenthal Christine Burty Fabrice Bonnet Dominique Costagliola Eric Jougla Caroline Semaille Philippe Morlat Dominique Salmon Patrice Cacoub Geneviève Chêne | 2008 | JAIDS Journal of Acquired Immune Deficiency Syndromes2008，，： | 1 |
| 5 | Liver disease as a major cause of death among HIV infected patients:role of hepatitis C and B viruses and alcohol显示文摘 | Salmon-Ceron D Lewden C Morlat P | 2005 | Hepatol2005，42，6： | 1 |
| 6 | Photodegradationof polypropylene nanocomposites显示文摘 | Mailhot B Morlat S Gardette J L | 2003 | Polym Degrad Stab2003，82，2： | 1 |
| 7 | HIV infected adults with a CD4 cell count greater than 500 cells/rnm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population显示文摘 | Lewden C Chene G Morlat P | 2007 | J Acquir Immune Defic Syndr2007，46，1： | 1 |
| 8 | Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS显示文摘 | Lewden C Salmon D Morlat P | 2005 | Int J Epidemiol2005，34，1： | 1 |
| 9 | HIV-infected adults with a CD4cell count greater than 500cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population显示文摘 | Lewden C Chene G Morlat P | 2007 | J Acquir Immune Defic Syndr2007，46，1： | 1 |
| 10 | Photodegradation of polypropylene nanocomposites 显示文摘 | MAILHOT B MORLAT S GARDETTE J | 2003 | Polym Degrad Stab2003，82，： | 1 |
| 11 | Photodegradation of polypropylene nanocomposites显示文摘 | MAILHOT B MORLAT S GARDETTE J | 2003 | Polym Degrad Stab2003，82，： | 1 |
| 12 | Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection : a double-blind, randomized trial显示文摘 | Leport C Chene G Morlat P | 1996 | J Infect Dis1996，173，1： | 1 |
| 13 | First results on the effects of controlled permanent cover on the vine and wine, in combination with soil diversity of Saumur vineyards显示文摘 | Riou C Morlat R | 1996 | Seizieme conference du Columa1996，3，： | 1 |
| 14 | HIV-infected adults with aCD4cell count greater than 500cells/mm3 on long-term combina-tion antiretroviral therapy reach same mortality rates as the gener-al population显示文摘 | Lewden C Chene G Morlat P | 2007 | J Acquir Immune Defic Syndr2007，46，1： | 1 |
| 15 | Liver disease as a major cause of death among HIV infected patients:role of hepatitis C and B viruses and alcohol显示文摘 | Salmon-Ceron D Lewden C Morlat P | 2005 | Hepatology2005，42，6： | 1 |
| 16 | Liver disease as amjot cause of death among HIV infected patients : role of hepatitis C and B viruses and alcohol 显示文摘 | Sshllon - Ceron D Lewden C Morlat P | 2005 | Hepatology2005，42，6： | 1 |
| 17 | Liver disease as a ma-jor cause of death among HIV infected patients:role of hepatitis C andB viruses and alcohol显示文摘 | Salmon-Ceron D Lewden C Morlat P | 2005 | J Hepatol2005，42，6： | 1 |
| 18 | Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients显示文摘AIM To describe factors associated with treatment failure and frequency of resistance-associated substitutions(RAS).METHODS Human immunodeficiency virus(HIV)/hepatitis C virus(HCV) coinfected patients starting a first direct-acting antiviral(DAA) regimen before February 2016 and included in the French ANRS CO13 HEPAVIH cohort were eligible. Failure was defined as:(1) non-response [HCV-RNA remained detectable during treatment, at end of treatment(EOT)]; and(2) relapse(HCVRNA suppressed at EOT but detectable thereafter). Sequencing analysis was performed to describe prevalence of drug class-specific RAS. Factors associated with failure were determined using logistic regression models.RESULTS Among 559 patients, 77% had suppressed plasma HIV-RNA < 50 copies/mL at DAA treatment initiation, 41% were cirrhotic, and 68% were HCV treatmentexperienced. Virological treatment failures occurred in 22 patients and were mainly relapses(17, 77%) then undefined failures(3, 14%) and non-responses(2, 9%). Mean treatment duration was 16 wk overall. Posttreatment NS3, NS5 A or NS5 B RAS were detected in 10/14 patients with samples available for sequencing analysis. After adjustment for age, sex, ribavirin use, HCV genotype and treatment duration, low platelet count was the only factor significantly associated with a higher risk of failure(OR: 6.5; 95%CI: 1.8-22.6). CONCLUSION Only 3.9% HIV-HCV coinfected patients failed DAA regimens and RAS were found in 70% of those failing. Low platelet count was independently associated with virological failure. | Dominique Salmon Pascale Trimoulet Camille Gilbert Caroline Solas Eva Lafourcade Julie Chas Lionel Piroth Karine Lacombe Christine Katlama Gilles Peytavin Hugues Aumaitre Laurent Alric Franoois Boué Philippe Morlat Isabelle Poizot-Martin Eric Billaud Eric Rosenthal Alissa Naqvi Patrick Miailhes Firouzé Bani-Sadr Laure Esterle Patrizia Carrieri Franoois Dabis Philippe Sogni Linda Wittkop 无 | 2018 | World Journal of Hepatology2018，10，11： | 1 |
| 19 | Correlation skindisorders with CD4 lymphocyte counts patients with HIV/AIDS显示文摘 | MignardM Sp ira R M Morlat P | 1998 | J Am Acad Dermatol1998，39，： | 1 |
| 20 | Correlation skin disorders with CD4 lymphocyte counts patients with HIV/AIDS显示文摘 | Mignard M Spira R M Morlat P | 1998 | J Am Acad Dermatol1998，39，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员